These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 420168)

  • 1. Activated partial thromboplastin time and minor coagulopathies.
    Hathaway WE; Assmus SL; Montgomery RR; Dubansky AS
    Am J Clin Pathol; 1979 Jan; 71(1):22-5. PubMed ID: 420168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies.
    Turi DC; Peerschke EI
    Am J Clin Pathol; 1986 Jan; 85(1):43-9. PubMed ID: 3940420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the sensitivity of commercial APTT reagents in the detection of mild coagulopathies.
    Marlar RA; Bauer PJ; Endres-Brooks JL; Montgomery RR; Miller CM; Schanen MM
    Am J Clin Pathol; 1984 Oct; 82(4):436-9. PubMed ID: 6475840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions.
    Barna L; Triplett DA
    Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.
    Shetty S; Ghosh K; Mohanty D
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):493-7. PubMed ID: 12851537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences for the APTT due to direct action of factor XIa on factor X, resulting in bypassing factors VIII-IX.
    Kluft C; van Leuven CJ
    Thromb Res; 2015 Jan; 135(1):198-204. PubMed ID: 25467084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats].
    Deniz A; Mischke R; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII.
    Asmis LM; Sulzer I; Furlan M; Lämmle B
    Thromb Res; 2002 Mar; 105(6):463-70. PubMed ID: 12091043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple screening tests for the diagnosis of isolated clotting factor defects. With special reference to 'contact factor' defects.
    Ingram GI; Knights SF; Arocha-Piñango CL; Shepperd JP; Pérez-Requejo JL; Mills DK
    J Clin Pathol; 1975 Jul; 28(7):524-30. PubMed ID: 1080159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first cases of Fitzgerald factor deficiency in the Orient: three cases in one family.
    Hayashi H; Koya H; Kuroda M; Kitazima K; Kimura I; Katori M; Oh-ishi S
    Acta Haematol; 1980; 63(2):107-13. PubMed ID: 6768213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method.
    Tripodi A; Poggio M; Scapellato L; Mannucci PM
    Haemostasis; 1989; 19(4):205-12. PubMed ID: 2509308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance characteristics of a new synthetic APTT reagent.
    Ts'ao C; Neofotistos D; Oropeza M; Rogan M; Santos M
    Clin Lab Haematol; 1998 Oct; 20(5):307-13. PubMed ID: 9807679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of factor VIII:C and factor IX activity in plasmas of haemophilic dogs on the activated partial thromboplastin time measured with two commercial reagents.
    Mischke R
    Haemophilia; 2000 May; 6(3):135-9. PubMed ID: 10792470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.